leisure time -WSS

leisure time

author：explore 2025-09-03 11:21:28 - browse：8

Perrigo Opill press photo – pharma coverage from STAT — Opill, the first over-the-counter birth control pill, is on its way to U.S. stores. Perrigo via AP

WASHINGTON — The first over-the-counter birth control pill will be available in U.S. stores later this month, allowing American women and teens to purchase contraceptive medication as easily as they buy aspirin.

Manufacturer Perrigo said Monday it has begun shipping the medication, Opill, to major retailers and pharmacies. A one-month supply will cost about $20 and a three-month supply will cost around $50, according to the company’s suggested retail price. It will also be sold online.

The launch has been closely watched since last July, when the Food and Drug Administration said the once-a-day Opill could be sold without a prescription. Ireland-based Perrigo noted there will be no age restrictions on sales, similar to other over-the-counter medications.

Opill is an older class of contraceptive, sometimes called minipills, that contain a single synthetic hormone, progestin, and generally carry fewer side effects than more popular combination estrogen and progestin pills.

Newsletters

Sign up for Morning Rounds

Understand how science, health policy, and medicine shape the world every day

Please enter a valid email address. Privacy Policy

The launch gives U.S. women another birth control option amid the legal and political battles over reproductive health, including the reversal of Roe v. Wade, which has upended abortion access across the U.S. Opill’s approval is unrelated to the ongoing court battles over the abortion pill mifepristone. And anti-abortion groups have generally emphasized that they do not oppose contraceptives to prevent pregnancies.

Birth control pills are available without a prescription across much of South America, Asia, and Africa.

The drug’s approval came despite some concerns by FDA scientists about the company’s results, including whether women with certain medical conditions would understand that they shouldn’t take the drug.

Dr. Verda Hicks, president of the American College of Obstetricians and Gynecologists, in a statement, said studies have shown that patients, including adolescents, can effectively screen themselves to use the pills.

— Matthew Perrone

Previous article： Psychedelics group wrestles with new pharma identity
Next article： What happened to the House vote on health price transparency?

leisure time

WSS

FDA panel to weigh safety of artificial wombs for preterm births

What happened to the House vote on health price transparency?

PBMs drew scrutiny in House hearing — and so did pharma

HHS secretary Becerra pressed on Change HealthCare cyberattack

Why depression after traumatic brain injury is distinct

House panel takes first step toward fixing drug shortages

hotspot

leisure time

Sign up for Morning Rounds

focus

BioMarin wins approval for gene therapy to treat hemophilia A

People with substance use disorder deserve online privacy

Cancer drug shortages should be causing more outrage

R.J. Reynolds sues to protect 'crisp' cigs from California flavor ban

Medicare proposal to cover medical devices draws a mixed reaction

How many hemophilia patients actually want gene therapy?

Heart attack and stroke risk calculators need revising

Ebola: Gilead Sciences antiviral shows promise as new treatment

Wildfire smoke exposes gaps in outdoor worker protections

Midwives could help bridge maternal health disparities in the U.S.

Wikipedia

As AI in medicine takes off, can 'human in the loop' prevent harm?

The unintended consequences of overturning Roe v. Wade

Medicare coverage of Wegovy, once blocked, now looks possible

Boston's new lab space is opening empty

Eli Lilly CEO gives to Mike Pence presidential super PAC

As AI in medicine takes off, can 'human in the loop' prevent harm?

hotspot

explore

leisure time

focus